HEADER HYDROLASE 10-AUG-05 2AMP TITLE CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO TITLE 2 IN COMPLEX WITH AN INHIBITOR N1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TGEV MAIN PROTEASE, 3CL-PRO; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRANSMISSIBLE GASTROENTERITIS VIRUS; SOURCE 3 ORGANISM_TAXID: 11149; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-1 KEYWDS ANTI-PARALLEL B-BARREL, ANTI-PARALLEL A-HELICES, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.YANG,X.XUE,K.YANG,Q.ZHAO,M.BARTLAM,Z.RAO REVDAT 4 23-OCT-24 2AMP 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 2AMP 1 VERSN REVDAT 2 04-OCT-05 2AMP 1 JRNL REVDAT 1 13-SEP-05 2AMP 0 JRNL AUTH H.YANG,W.XIE,X.XUE,K.YANG,J.MA,W.LIANG,Q.ZHAO,Z.ZHOU,D.PEI, JRNL AUTH 2 J.ZIEBUHR,R.HILGENFELD,K.Y.YUEN,L.WONG,G.GAO,S.CHEN,Z.CHEN, JRNL AUTH 3 D.MA,M.BARTLAM,Z.RAO JRNL TITL DESIGN OF WIDE-SPECTRUM INHIBITORS TARGETING CORONAVIRUS JRNL TITL 2 MAIN PROTEASES. JRNL REF PLOS BIOL. V. 3 324 2005 JRNL REFN ISSN 1544-9173 JRNL PMID 16128623 JRNL DOI 10.1371/JOURNAL.PBIO.0030324 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 868 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4594 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 90 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.020 REMARK 3 BOND ANGLES (DEGREES) : 1.940 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AMP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000034073. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18149 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES, (NH4)2SO4, MPD, DTT, DIOXANE, REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.29450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.17250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.11950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.17250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.29450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.11950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 ASN A 300 REMARK 465 LEU A 301 REMARK 465 GLN A 302 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 ASN B 300 REMARK 465 LEU B 301 REMARK 465 GLN B 302 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN B 153 N ILE B 155 1.96 REMARK 500 OG SER B 10 OE2 GLU B 14 1.97 REMARK 500 O TYR B 53 N ASN B 55 2.09 REMARK 500 O ASP B 245 N PHE B 247 2.09 REMARK 500 NH2 ARG A 4 O LYS B 136 2.13 REMARK 500 O LYS A 136 NH1 ARG B 4 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 54 NZ LYS A 260 2455 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL A 13 CB VAL A 13 CG1 -0.194 REMARK 500 VAL A 13 CB VAL A 13 CG2 -0.158 REMARK 500 GLU A 14 CD GLU A 14 OE1 -0.091 REMARK 500 GLU A 14 CD GLU A 14 OE2 -0.091 REMARK 500 PRO A 15 CB PRO A 15 CG -0.301 REMARK 500 VAL A 20 CB VAL A 20 CG2 -0.186 REMARK 500 TYR A 22 CE1 TYR A 22 CZ -0.109 REMARK 500 TYR A 22 CZ TYR A 22 CE2 -0.080 REMARK 500 TYR A 22 CE2 TYR A 22 CD2 -0.092 REMARK 500 VAL A 26 CB VAL A 26 CG1 -0.148 REMARK 500 MET A 161 C HIS A 162 N -0.258 REMARK 500 HIS A 162 C HIS A 163 N 0.175 REMARK 500 LEU A 262 C ASP A 263 N 0.143 REMARK 500 LYS B 5 CE LYS B 5 NZ -0.153 REMARK 500 MET B 6 CG MET B 6 SD -0.235 REMARK 500 MET B 6 SD MET B 6 CE -0.642 REMARK 500 PRO B 9 CB PRO B 9 CG -0.323 REMARK 500 MET B 190 SD MET B 190 CE 0.613 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 15 C - N - CD ANGL. DEV. = -14.1 DEGREES REMARK 500 LYS A 82 N - CA - C ANGL. DEV. = -17.4 DEGREES REMARK 500 LEU B 3 CA - CB - CG ANGL. DEV. = 16.9 DEGREES REMARK 500 MET B 190 CG - SD - CE ANGL. DEV. = 10.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 9 143.35 -36.33 REMARK 500 LEU A 27 -149.07 -152.87 REMARK 500 SER A 45 -94.62 -55.49 REMARK 500 HIS A 63 -7.97 -47.45 REMARK 500 SER A 66 121.44 179.99 REMARK 500 ASN A 70 -128.30 69.80 REMARK 500 SER A 78 145.56 -173.64 REMARK 500 GLU A 118 43.22 36.12 REMARK 500 SER A 123 158.56 175.99 REMARK 500 LYS A 136 70.21 -103.32 REMARK 500 ILE A 140 -164.09 -111.28 REMARK 500 CYS A 144 139.61 -39.74 REMARK 500 ASN A 153 -6.99 63.25 REMARK 500 HIS A 163 -49.05 -143.39 REMARK 500 ASP A 186 47.04 -73.53 REMARK 500 PRO A 188 49.73 -73.84 REMARK 500 THR A 195 134.12 -38.16 REMARK 500 ARG A 216 -23.17 -144.35 REMARK 500 PHE A 218 12.25 -67.14 REMARK 500 SER A 243 115.10 -164.45 REMARK 500 LYS A 270 36.83 -88.24 REMARK 500 PHE A 272 6.54 -69.35 REMARK 500 SER A 279 -13.44 73.75 REMARK 500 ILE A 293 -74.71 -61.69 REMARK 500 MET A 296 -165.18 -101.27 REMARK 500 TYR A 297 106.05 -51.89 REMARK 500 TYR B 22 89.04 -177.06 REMARK 500 HIS B 41 -2.16 -47.15 REMARK 500 VAL B 50 133.71 -25.12 REMARK 500 TYR B 53 -115.79 -64.84 REMARK 500 GLU B 54 -71.75 16.07 REMARK 500 ARG B 61 88.88 -64.50 REMARK 500 LEU B 62 -33.74 -32.71 REMARK 500 PHE B 65 160.69 -47.07 REMARK 500 ASN B 70 -154.28 65.82 REMARK 500 ASN B 71 47.64 -92.85 REMARK 500 VAL B 77 -83.81 -105.75 REMARK 500 SER B 78 -169.93 -104.02 REMARK 500 ALA B 79 120.81 -175.07 REMARK 500 ASN B 91 39.97 -90.00 REMARK 500 GLN B 92 86.11 -172.98 REMARK 500 LYS B 103 -160.53 -172.54 REMARK 500 VAL B 127 -156.82 -136.64 REMARK 500 SER B 138 48.36 -176.31 REMARK 500 ALA B 141 106.93 -50.83 REMARK 500 ASN B 153 110.29 65.90 REMARK 500 PRO B 188 55.90 -69.00 REMARK 500 THR B 195 146.58 -35.27 REMARK 500 ASN B 213 35.17 -89.99 REMARK 500 THR B 222 141.03 147.27 REMARK 500 REMARK 500 THIS ENTRY HAS 61 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 2 LEU B 3 138.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I12 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I12 B 2001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UJ1 RELATED DB: PDB REMARK 900 RELATED ID: 2AMD RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH 9IN REMARK 900 RELATED ID: 2AMQ RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH 3IH DBREF 2AMP A 1 302 UNP Q9IW06 R1AB_CVPPU 2879 3180 DBREF 2AMP B 1 302 UNP Q9IW06 R1AB_CVPPU 2879 3180 SEQADV 2AMP GLY A -1 UNP Q9IW06 CLONING ARTIFACT SEQADV 2AMP SER A 0 UNP Q9IW06 CLONING ARTIFACT SEQADV 2AMP GLY B -1 UNP Q9IW06 CLONING ARTIFACT SEQADV 2AMP SER B 0 UNP Q9IW06 CLONING ARTIFACT SEQRES 1 A 304 GLY SER SER GLY LEU ARG LYS MET ALA GLN PRO SER GLY SEQRES 2 A 304 LEU VAL GLU PRO CYS ILE VAL ARG VAL SER TYR GLY ASN SEQRES 3 A 304 ASN VAL LEU ASN GLY LEU TRP LEU GLY ASP GLU VAL ILE SEQRES 4 A 304 CYS PRO ARG HIS VAL ILE ALA SER ASP THR THR ARG VAL SEQRES 5 A 304 ILE ASN TYR GLU ASN GLU MET SER SER VAL ARG LEU HIS SEQRES 6 A 304 ASN PHE SER VAL SER LYS ASN ASN VAL PHE LEU GLY VAL SEQRES 7 A 304 VAL SER ALA ARG TYR LYS GLY VAL ASN LEU VAL LEU LYS SEQRES 8 A 304 VAL ASN GLN VAL ASN PRO ASN THR PRO GLU HIS LYS PHE SEQRES 9 A 304 LYS SER ILE LYS ALA GLY GLU SER PHE ASN ILE LEU ALA SEQRES 10 A 304 CYS TYR GLU GLY CYS PRO GLY SER VAL TYR GLY VAL ASN SEQRES 11 A 304 MET ARG SER GLN GLY THR ILE LYS GLY SER PHE ILE ALA SEQRES 12 A 304 GLY THR CYS GLY SER VAL GLY TYR VAL LEU GLU ASN GLY SEQRES 13 A 304 ILE LEU TYR PHE VAL TYR MET HIS HIS LEU GLU LEU GLY SEQRES 14 A 304 ASN GLY SER HIS VAL GLY SER ASN PHE GLU GLY GLU MET SEQRES 15 A 304 TYR GLY GLY TYR GLU ASP GLN PRO SER MET GLN LEU GLU SEQRES 16 A 304 GLY THR ASN VAL MET SER SER ASP ASN VAL VAL ALA PHE SEQRES 17 A 304 LEU TYR ALA ALA LEU ILE ASN GLY GLU ARG TRP PHE VAL SEQRES 18 A 304 THR ASN THR SER MET SER LEU GLU SER TYR ASN THR TRP SEQRES 19 A 304 ALA LYS THR ASN SER PHE THR GLU LEU SER SER THR ASP SEQRES 20 A 304 ALA PHE SER MET LEU ALA ALA LYS THR GLY GLN SER VAL SEQRES 21 A 304 GLU LYS LEU LEU ASP SER ILE VAL ARG LEU ASN LYS GLY SEQRES 22 A 304 PHE GLY GLY ARG THR ILE LEU SER TYR GLY SER LEU CYS SEQRES 23 A 304 ASP GLU PHE THR PRO THR GLU VAL ILE ARG GLN MET TYR SEQRES 24 A 304 GLY VAL ASN LEU GLN SEQRES 1 B 304 GLY SER SER GLY LEU ARG LYS MET ALA GLN PRO SER GLY SEQRES 2 B 304 LEU VAL GLU PRO CYS ILE VAL ARG VAL SER TYR GLY ASN SEQRES 3 B 304 ASN VAL LEU ASN GLY LEU TRP LEU GLY ASP GLU VAL ILE SEQRES 4 B 304 CYS PRO ARG HIS VAL ILE ALA SER ASP THR THR ARG VAL SEQRES 5 B 304 ILE ASN TYR GLU ASN GLU MET SER SER VAL ARG LEU HIS SEQRES 6 B 304 ASN PHE SER VAL SER LYS ASN ASN VAL PHE LEU GLY VAL SEQRES 7 B 304 VAL SER ALA ARG TYR LYS GLY VAL ASN LEU VAL LEU LYS SEQRES 8 B 304 VAL ASN GLN VAL ASN PRO ASN THR PRO GLU HIS LYS PHE SEQRES 9 B 304 LYS SER ILE LYS ALA GLY GLU SER PHE ASN ILE LEU ALA SEQRES 10 B 304 CYS TYR GLU GLY CYS PRO GLY SER VAL TYR GLY VAL ASN SEQRES 11 B 304 MET ARG SER GLN GLY THR ILE LYS GLY SER PHE ILE ALA SEQRES 12 B 304 GLY THR CYS GLY SER VAL GLY TYR VAL LEU GLU ASN GLY SEQRES 13 B 304 ILE LEU TYR PHE VAL TYR MET HIS HIS LEU GLU LEU GLY SEQRES 14 B 304 ASN GLY SER HIS VAL GLY SER ASN PHE GLU GLY GLU MET SEQRES 15 B 304 TYR GLY GLY TYR GLU ASP GLN PRO SER MET GLN LEU GLU SEQRES 16 B 304 GLY THR ASN VAL MET SER SER ASP ASN VAL VAL ALA PHE SEQRES 17 B 304 LEU TYR ALA ALA LEU ILE ASN GLY GLU ARG TRP PHE VAL SEQRES 18 B 304 THR ASN THR SER MET SER LEU GLU SER TYR ASN THR TRP SEQRES 19 B 304 ALA LYS THR ASN SER PHE THR GLU LEU SER SER THR ASP SEQRES 20 B 304 ALA PHE SER MET LEU ALA ALA LYS THR GLY GLN SER VAL SEQRES 21 B 304 GLU LYS LEU LEU ASP SER ILE VAL ARG LEU ASN LYS GLY SEQRES 22 B 304 PHE GLY GLY ARG THR ILE LEU SER TYR GLY SER LEU CYS SEQRES 23 B 304 ASP GLU PHE THR PRO THR GLU VAL ILE ARG GLN MET TYR SEQRES 24 B 304 GLY VAL ASN LEU GLN HET I12 A1001 44 HET I12 B2001 44 HETNAM I12 N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]-L-ALANYL-L-VALYL- HETNAM 2 I12 N~1~-((1S)-4-ETHOXY-4-OXO-1-{[(3S)-2-OXOPYRROLIDIN-3- HETNAM 3 I12 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE HETSYN I12 (E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5- HETSYN 2 I12 METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}- HETSYN 3 I12 BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO- HETSYN 4 I12 PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER FORMUL 3 I12 2(C30 H46 N6 O8) FORMUL 5 HOH *90(H2 O) HELIX 1 1 SER A 10 GLU A 14 5 5 HELIX 2 2 HIS A 41 ILE A 43 5 3 HELIX 3 3 ASN A 52 SER A 59 1 8 HELIX 4 4 VAL A 60 HIS A 63 5 4 HELIX 5 5 MET A 180 TYR A 184 5 5 HELIX 6 6 SER A 199 ASN A 213 1 15 HELIX 7 7 SER A 225 THR A 235 1 11 HELIX 8 8 SER A 243 ALA A 246 5 4 HELIX 9 9 PHE A 247 GLY A 255 1 9 HELIX 10 10 SER A 257 ASN A 269 1 13 HELIX 11 11 THR A 288 MET A 296 1 9 HELIX 12 12 VAL B 13 PRO B 15 5 3 HELIX 13 13 HIS B 41 ILE B 43 5 3 HELIX 14 14 TYR B 53 VAL B 60 5 8 HELIX 15 15 ARG B 61 PHE B 65 5 5 HELIX 16 16 MET B 180 TYR B 184 5 5 HELIX 17 17 SER B 199 ASN B 213 1 15 HELIX 18 18 SER B 225 ASN B 236 1 12 HELIX 19 19 PHE B 247 THR B 254 1 8 HELIX 20 20 SER B 257 ASN B 269 1 13 HELIX 21 21 THR B 288 MET B 296 1 9 SHEET 1 A 7 VAL A 72 LEU A 74 0 SHEET 2 A 7 PHE A 65 LYS A 69 -1 N VAL A 67 O LEU A 74 SHEET 3 A 7 ILE A 17 TYR A 22 -1 N ARG A 19 O SER A 68 SHEET 4 A 7 ASN A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 A 7 GLU A 35 PRO A 39 -1 O GLU A 35 N LEU A 32 SHEET 6 A 7 ASN A 85 VAL A 90 -1 O LEU A 86 N CYS A 38 SHEET 7 A 7 VAL A 76 LYS A 82 -1 N VAL A 77 O LYS A 89 SHEET 1 B 5 HIS A 100 PHE A 102 0 SHEET 2 B 5 ILE A 155 GLU A 165 1 O LEU A 156 N LYS A 101 SHEET 3 B 5 VAL A 147 GLU A 152 -1 N GLY A 148 O TYR A 160 SHEET 4 B 5 SER A 110 TYR A 117 -1 N ASN A 112 O TYR A 149 SHEET 5 B 5 CYS A 120 ASN A 128 -1 O CYS A 120 N TYR A 117 SHEET 1 C 3 HIS A 100 PHE A 102 0 SHEET 2 C 3 ILE A 155 GLU A 165 1 O LEU A 156 N LYS A 101 SHEET 3 C 3 HIS A 171 SER A 174 -1 O VAL A 172 N LEU A 164 SHEET 1 D 5 ILE B 17 TYR B 22 0 SHEET 2 D 5 ASN B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 3 D 5 GLU B 35 PRO B 39 -1 O ILE B 37 N LEU B 30 SHEET 4 D 5 ASN B 85 VAL B 90 -1 O LEU B 86 N CYS B 38 SHEET 5 D 5 VAL B 76 LYS B 82 -1 N VAL B 77 O LYS B 89 SHEET 1 E 2 VAL B 67 LYS B 69 0 SHEET 2 E 2 VAL B 72 LEU B 74 -1 O VAL B 72 N LYS B 69 SHEET 1 F 5 HIS B 100 PHE B 102 0 SHEET 2 F 5 LEU B 156 GLU B 165 1 O LEU B 156 N LYS B 101 SHEET 3 F 5 VAL B 147 LEU B 151 -1 N VAL B 150 O TYR B 157 SHEET 4 F 5 SER B 110 TYR B 117 -1 N LEU B 114 O VAL B 147 SHEET 5 F 5 CYS B 120 ASN B 128 -1 O VAL B 127 N PHE B 111 SHEET 1 G 3 HIS B 100 PHE B 102 0 SHEET 2 G 3 LEU B 156 GLU B 165 1 O LEU B 156 N LYS B 101 SHEET 3 G 3 HIS B 171 SER B 174 -1 O VAL B 172 N LEU B 164 LINK SG CYS A 144 C21 I12 A1001 1555 1555 1.81 LINK SG CYS B 144 C21 I12 B2001 1555 1555 1.82 SITE 1 AC1 16 THR A 47 ILE A 51 PHE A 139 ILE A 140 SITE 2 AC1 16 GLY A 142 CYS A 144 HIS A 162 HIS A 163 SITE 3 AC1 16 LEU A 164 GLU A 165 HIS A 171 ASP A 186 SITE 4 AC1 16 PRO A 188 SER A 189 MET A 190 HOH A1009 SITE 1 AC2 17 THR B 47 ILE B 51 PHE B 139 ILE B 140 SITE 2 AC2 17 ALA B 141 GLY B 142 CYS B 144 HIS B 162 SITE 3 AC2 17 HIS B 163 LEU B 164 GLU B 165 GLY B 167 SITE 4 AC2 17 HIS B 171 ASP B 186 PRO B 188 SER B 189 SITE 5 AC2 17 LYS B 270 CRYST1 66.589 90.239 110.345 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015017 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011082 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009062 0.00000